Two years of tamoxifen followed by 3 years of anastrozole versus 5 years of tamoxifen alone in postmenopausal women with hormone-responsive early breast cancer: Efficacy results from 3,714 patients from the Austrian Breast and Colorectal Cancer Study Group (ABCSG) trial 8.

被引：1

作者：

Dubsky, P. C.

Jakesz, R.

Greil, R.

Heck, D.

Stoeger, H.

Kwasny, W.

Menzel, C.

Singer, C. F.

Medl, M.

Gnant, M.

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Univ Hosp Salzburg, Salzburg, Austria

[3] Hosp Barmherzige Schwestern Linz, Linz, Austria

[4] Med Univ Graz, Graz, Austria

[5] Hosp Wr Neustadt, Wr Neustadt, Austria

[6] Paracelsus Univ Salzburg, Salzburg, Austria

[7] Med Univ Vienna, Gen Hosp, Vienna, Austria

[8] Hanusch Med Ctr, Vienna, Austria

来源：

关键词：

D O I：

10.1200/jco.2010.28.15_suppl.534

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

534

引用

页数：1